Global Immuno-Oncology Market Insights and Forecast to 2028

Report ID: 1240477 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Immuno-Oncology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Immune Checkpoint Inhibitors
        1.2.3 Cytokine-Based Immunotherapy
        1.2.4 Cancer Vaccines
        1.2.5 CAR-T Cell Therapy
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Immuno-Oncology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Drugstores
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Immuno-Oncology Market Perspective (2017-2028)
    2.2 Immuno-Oncology Growth Trends by Region
        2.2.1 Immuno-Oncology Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Immuno-Oncology Historic Market Size by Region (2017-2022)
        2.2.3 Immuno-Oncology Forecasted Market Size by Region (2023-2028)
    2.3 Immuno-Oncology Market Dynamics
        2.3.1 Immuno-Oncology Industry Trends
        2.3.2 Immuno-Oncology Market Drivers
        2.3.3 Immuno-Oncology Market Challenges
        2.3.4 Immuno-Oncology Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Immuno-Oncology Players by Revenue
        3.1.1 Global Top Immuno-Oncology Players by Revenue (2017-2022)
        3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2017-2022)
    3.2 Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Immuno-Oncology Revenue
    3.4 Global Immuno-Oncology Market Concentration Ratio
        3.4.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2021
    3.5 Immuno-Oncology Key Players Head office and Area Served
    3.6 Key Players Immuno-Oncology Product Solution and Service
    3.7 Date of Enter into Immuno-Oncology Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Oncology Breakdown Data by Type
    4.1 Global Immuno-Oncology Historic Market Size by Type (2017-2022)
    4.2 Global Immuno-Oncology Forecasted Market Size by Type (2023-2028)
5 Immuno-Oncology Breakdown Data by Application
    5.1 Global Immuno-Oncology Historic Market Size by Application (2017-2022)
    5.2 Global Immuno-Oncology Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Immuno-Oncology Market Size (2017-2028)
    6.2 North America Immuno-Oncology Market Size by Type
        6.2.1 North America Immuno-Oncology Market Size by Type (2017-2022)
        6.2.2 North America Immuno-Oncology Market Size by Type (2023-2028)
        6.2.3 North America Immuno-Oncology Market Share by Type (2017-2028)
    6.3 North America Immuno-Oncology Market Size by Application
        6.3.1 North America Immuno-Oncology Market Size by Application (2017-2022)
        6.3.2 North America Immuno-Oncology Market Size by Application (2023-2028)
        6.3.3 North America Immuno-Oncology Market Share by Application (2017-2028)
    6.4 North America Immuno-Oncology Market Size by Country
        6.4.1 North America Immuno-Oncology Market Size by Country (2017-2022)
        6.4.2 North America Immuno-Oncology Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Immuno-Oncology Market Size (2017-2028)
    7.2 Europe Immuno-Oncology Market Size by Type
        7.2.1 Europe Immuno-Oncology Market Size by Type (2017-2022)
        7.2.2 Europe Immuno-Oncology Market Size by Type (2023-2028)
        7.2.3 Europe Immuno-Oncology Market Share by Type (2017-2028)
    7.3 Europe Immuno-Oncology Market Size by Application
        7.3.1 Europe Immuno-Oncology Market Size by Application (2017-2022)
        7.3.2 Europe Immuno-Oncology Market Size by Application (2023-2028)
        7.3.3 Europe Immuno-Oncology Market Share by Application (2017-2028)
    7.4 Europe Immuno-Oncology Market Size by Country
        7.4.1 Europe Immuno-Oncology Market Size by Country (2017-2022)
        7.4.2 Europe Immuno-Oncology Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Immuno-Oncology Market Size (2017-2028)
    8.2 Asia-Pacific Immuno-Oncology Market Size by Type
        8.2.1 Asia-Pacific Immuno-Oncology Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Immuno-Oncology Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Immuno-Oncology Market Share by Type (2017-2028)
    8.3 Asia-Pacific Immuno-Oncology Market Size by Application
        8.3.1 Asia-Pacific Immuno-Oncology Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Immuno-Oncology Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Immuno-Oncology Market Share by Application (2017-2028)
    8.4 Asia-Pacific Immuno-Oncology Market Size by Region
        8.4.1 Asia-Pacific Immuno-Oncology Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Immuno-Oncology Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Immuno-Oncology Market Size (2017-2028)
    9.2 Latin America Immuno-Oncology Market Size by Type
        9.2.1 Latin America Immuno-Oncology Market Size by Type (2017-2022)
        9.2.2 Latin America Immuno-Oncology Market Size by Type (2023-2028)
        9.2.3 Latin America Immuno-Oncology Market Share by Type (2017-2028)
    9.3 Latin America Immuno-Oncology Market Size by Application
        9.3.1 Latin America Immuno-Oncology Market Size by Application (2017-2022)
        9.3.2 Latin America Immuno-Oncology Market Size by Application (2023-2028)
        9.3.3 Latin America Immuno-Oncology Market Share by Application (2017-2028)
    9.4 Latin America Immuno-Oncology Market Size by Country
        9.4.1 Latin America Immuno-Oncology Market Size by Country (2017-2022)
        9.4.2 Latin America Immuno-Oncology Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Immuno-Oncology Market Size (2017-2028)
    10.2 Middle East & Africa Immuno-Oncology Market Size by Type
        10.2.1 Middle East & Africa Immuno-Oncology Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Immuno-Oncology Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Immuno-Oncology Market Share by Type (2017-2028)
    10.3 Middle East & Africa Immuno-Oncology Market Size by Application
        10.3.1 Middle East & Africa Immuno-Oncology Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Immuno-Oncology Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Immuno-Oncology Market Share by Application (2017-2028)
    10.4 Middle East & Africa Immuno-Oncology Market Size by Country
        10.4.1 Middle East & Africa Immuno-Oncology Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Immuno-Oncology Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Bristol-Myers Squibb
        11.1.1 Bristol-Myers Squibb Company Details
        11.1.2 Bristol-Myers Squibb Business Overview
        11.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
        11.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2017-2022)
        11.1.5 Bristol-Myers Squibb Recent Developments
    11.2 Merck & Co., Inc.
        11.2.1 Merck & Co., Inc. Company Details
        11.2.2 Merck & Co., Inc. Business Overview
        11.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
        11.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2017-2022)
        11.2.5 Merck & Co., Inc. Recent Developments
    11.3 Roche AG
        11.3.1 Roche AG Company Details
        11.3.2 Roche AG Business Overview
        11.3.3 Roche AG Immuno-Oncology Introduction
        11.3.4 Roche AG Revenue in Immuno-Oncology Business (2017-2022)
        11.3.5 Roche AG Recent Developments
    11.4 AstraZeneca, Plc
        11.4.1 AstraZeneca, Plc Company Details
        11.4.2 AstraZeneca, Plc Business Overview
        11.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
        11.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2017-2022)
        11.4.5 AstraZeneca, Plc Recent Developments
    11.5 Sanofi S.A.
        11.5.1 Sanofi S.A. Company Details
        11.5.2 Sanofi S.A. Business Overview
        11.5.3 Sanofi S.A. Immuno-Oncology Introduction
        11.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2017-2022)
        11.5.5 Sanofi S.A. Recent Developments
    11.6 Dendreon Pharmaceuticals
        11.6.1 Dendreon Pharmaceuticals Company Details
        11.6.2 Dendreon Pharmaceuticals Business Overview
        11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
        11.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2017-2022)
        11.6.5 Dendreon Pharmaceuticals Recent Developments
    11.7 Novartis
        11.7.1 Novartis Company Details
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Immuno-Oncology Introduction
        11.7.4 Novartis Revenue in Immuno-Oncology Business (2017-2022)
        11.7.5 Novartis Recent Developments
    11.8 Gilead Sciences Inc.
        11.8.1 Gilead Sciences Inc. Company Details
        11.8.2 Gilead Sciences Inc. Business Overview
        11.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
        11.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2017-2022)
        11.8.5 Gilead Sciences Inc. Recent Developments
    11.9 Merck KGaA
        11.9.1 Merck KGaA Company Details
        11.9.2 Merck KGaA Business Overview
        11.9.3 Merck KGaA Immuno-Oncology Introduction
        11.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2017-2022)
        11.9.5 Merck KGaA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Immuno-Oncology Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Immune Checkpoint Inhibitors
    Table 3. Key Players of Cytokine-Based Immunotherapy
    Table 4. Key Players of Cancer Vaccines
    Table 5. Key Players of CAR-T Cell Therapy
    Table 6. Key Players of Others
    Table 7. Global Immuno-Oncology Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Immuno-Oncology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Immuno-Oncology Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Immuno-Oncology Market Share by Region (2017-2022)
    Table 11. Global Immuno-Oncology Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Immuno-Oncology Market Share by Region (2023-2028)
    Table 13. Immuno-Oncology Market Trends
    Table 14. Immuno-Oncology Market Drivers
    Table 15. Immuno-Oncology Market Challenges
    Table 16. Immuno-Oncology Market Restraints
    Table 17. Global Immuno-Oncology Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Immuno-Oncology Revenue Share by Players (2017-2022)
    Table 19. Global Top Immuno-Oncology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2021)
    Table 20. Ranking of Global Top Immuno-Oncology Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Immuno-Oncology Product Solution and Service
    Table 24. Date of Enter into Immuno-Oncology Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Immuno-Oncology Revenue Market Share by Type (2017-2022)
    Table 28. Global Immuno-Oncology Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Immuno-Oncology Revenue Market Share by Type (2023-2028)
    Table 30. Global Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Immuno-Oncology Revenue Share by Application (2017-2022)
    Table 32. Global Immuno-Oncology Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Immuno-Oncology Revenue Share by Application (2023-2028)
    Table 34. North America Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Immuno-Oncology Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Immuno-Oncology Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Immuno-Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Immuno-Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Immuno-Oncology Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Immuno-Oncology Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Immuno-Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Immuno-Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Immuno-Oncology Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Immuno-Oncology Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Immuno-Oncology Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Immuno-Oncology Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Immuno-Oncology Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Immuno-Oncology Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Immuno-Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Immuno-Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Immuno-Oncology Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Immuno-Oncology Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Immuno-Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Immuno-Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Bristol-Myers Squibb Company Details
    Table 65. Bristol-Myers Squibb Business Overview
    Table 66. Bristol-Myers Squibb Immuno-Oncology Product
    Table 67. Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
    Table 68. Bristol-Myers Squibb Recent Developments
    Table 69. Merck & Co., Inc. Company Details
    Table 70. Merck & Co., Inc. Business Overview
    Table 71. Merck & Co., Inc. Immuno-Oncology Product
    Table 72. Merck & Co., Inc. Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
    Table 73. Merck & Co., Inc. Recent Developments
    Table 74. Roche AG Company Details
    Table 75. Roche AG Business Overview
    Table 76. Roche AG Immuno-Oncology Product
    Table 77. Roche AG Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
    Table 78. Roche AG Recent Developments
    Table 79. AstraZeneca, Plc Company Details
    Table 80. AstraZeneca, Plc Business Overview
    Table 81. AstraZeneca, Plc Immuno-Oncology Product
    Table 82. AstraZeneca, Plc Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
    Table 83. AstraZeneca, Plc Recent Developments
    Table 84. Sanofi S.A. Company Details
    Table 85. Sanofi S.A. Business Overview
    Table 86. Sanofi S.A. Immuno-Oncology Product
    Table 87. Sanofi S.A. Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
    Table 88. Sanofi S.A. Recent Developments
    Table 89. Dendreon Pharmaceuticals Company Details
    Table 90. Dendreon Pharmaceuticals Business Overview
    Table 91. Dendreon Pharmaceuticals Immuno-Oncology Product
    Table 92. Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
    Table 93. Dendreon Pharmaceuticals Recent Developments
    Table 94. Novartis Company Details
    Table 95. Novartis Business Overview
    Table 96. Novartis Immuno-Oncology Product
    Table 97. Novartis Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
    Table 98. Novartis Recent Developments
    Table 99. Gilead Sciences Inc. Company Details
    Table 100. Gilead Sciences Inc. Business Overview
    Table 101. Gilead Sciences Inc. Immuno-Oncology Product
    Table 102. Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
    Table 103. Gilead Sciences Inc. Recent Developments
    Table 104. Merck KGaA Company Details
    Table 105. Merck KGaA Business Overview
    Table 106. Merck KGaA Immuno-Oncology Product
    Table 107. Merck KGaA Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
    Table 108. Merck KGaA Recent Developments
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immuno-Oncology Market Share by Type: 2021 VS 2028
    Figure 2. Immune Checkpoint Inhibitors Features
    Figure 3. Cytokine-Based Immunotherapy Features
    Figure 4. Cancer Vaccines Features
    Figure 5. CAR-T Cell Therapy Features
    Figure 6. Others Features
    Figure 7. Global Immuno-Oncology Market Share by Application: 2021 VS 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Drugstores Case Studies
    Figure 10. Others Case Studies
    Figure 11. Immuno-Oncology Report Years Considered
    Figure 12. Global Immuno-Oncology Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Immuno-Oncology Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Immuno-Oncology Market Share by Region: 2021 VS 2028
    Figure 15. Global Immuno-Oncology Market Share by Players in 2021
    Figure 16. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Immuno-Oncology Revenue in 2021
    Figure 18. North America Immuno-Oncology Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Immuno-Oncology Market Size Market Share by Type (2017-2028)
    Figure 20. North America Immuno-Oncology Market Size Market Share by Application (2017-2028)
    Figure 21. North America Immuno-Oncology Market Size Share by Country (2017-2028)
    Figure 22. United States Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Immuno-Oncology Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Immuno-Oncology Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Immuno-Oncology Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Immuno-Oncology Market Size Share by Country (2017-2028)
    Figure 28. Germany Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Immuno-Oncology Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Immuno-Oncology Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Immuno-Oncology Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Immuno-Oncology Market Size Share by Region (2017-2028)
    Figure 38. China Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America Immuno-Oncology Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Immuno-Oncology Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Immuno-Oncology Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Immuno-Oncology Market Size Share by Country (2017-2028)
    Figure 48. Mexico Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Immuno-Oncology Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Immuno-Oncology Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Immuno-Oncology Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Immuno-Oncology Market Size Share by Country (2017-2028)
    Figure 54. Turkey Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
    Figure 58. Merck & Co., Inc. Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
    Figure 59. Roche AG Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
    Figure 60. AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
    Figure 61. Sanofi S.A. Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
    Figure 62. Dendreon Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
    Figure 63. Novartis Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
    Figure 64. Gilead Sciences Inc. Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
    Figure 65. Merck KGaA Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Frequently Asked Questions
Immuno-Oncology report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immuno-Oncology report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immuno-Oncology report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Traction Converter

Traction Converter market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More